Clinical impact of frailty after durable left ventricular assist device implantation

30 August 2025 (08:45 - 08:55)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Shingo Kazama

Nagoya University Graduate School of Medicine, Nagoya (Japan)

5 More presentations in this session

Presentation thumbnail

Equivalent improvement in exercise capacity after mechanical circulatory support compared to heart transplant in advanced heart failure

Doctor H. Lo (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Impact of HF pharmacological therapy on the durability of favorable response after LVAD weaning: a VAD wean registry analysis

Doctor S. Drakos (Salt Lake City, US)

Abstract Slides Video

Presentation thumbnail

Frailty and obesity in heart transplant recipients: impact on post-transplant mortality

Doctor T. Goubar (Sydney, AU)

Abstract Slides Video

Presentation thumbnail

Impact of delayed heparin bridging on bleeding and stroke after heartmate 3 left ventricular assist device implantation

Mr P. Jahangiri (Rotterdam, NL)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of antithrombotic regimens in patients with durable left ventricular assist devices: a systematic review and bayesian network meta-analysis

Ms M. Ramos Miranda (BR)

Abstract Slides Video

Access the full session

Session thumbnail

Progress in advanced heart failure therapy

The Event

Event poster

ESC Congress 2025

30 August 2025 08:45 CET

You may be interested in

Congress Session

Progress in advanced heart failure therapy

Congress Session

Frailty in heart failure

Congress Presentation

Frailty trajectories and their associations with short and long-term clinical outcomes in patients with heart failure: an analysis of over 400,000 individuals using a primary care database in the UK.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources